Next |
home / stock / teva / teva message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts trading | JLS | investorshub | 05/08/2023 9:55:40 PM |
$TEVA The trading | Zilla | investorshub | 05/08/2023 8:56:28 PM |
and the shorts continue | Tigerbalsam | investorshub | 05/08/2023 3:10:48 AM |
Time for a bounce? | JLS | investorshub | 05/06/2023 5:42:43 PM |
$TEVA good read | WovenO2 | investorshub | 05/06/2023 3:13:04 PM |
$TEVA short data if anyone is interested | altruism | investorshub | 05/06/2023 1:20:35 PM |
Price gaining | JLS | investorshub | 05/05/2023 2:56:58 PM |
MomentumIts trading last trade up | Zilla | investorshub | 05/04/2023 10:16:26 PM |
Found an interesting article | WovenO2 | investorshub | 05/04/2023 1:28:41 PM |
Price now | ClayTrader | investorshub | 05/03/2023 1:57:50 PM |
$TEVA must see | Tigerbalsam | investorshub | 05/02/2023 10:00:18 PM |
short data if anyone is interested | J Pow Wannabe | investorshub | 04/30/2023 7:13:57 AM |
Price now last up | Zilla | investorshub | 04/28/2023 6:02:19 PM |
$TEVA The now last trade up | WovenO2 | investorshub | 04/28/2023 5:51:58 AM |
$TEVA Price trading | FUNMAN | investorshub | 04/27/2023 8:39:37 AM |
$TEVA short squeeze article | weedtrader420 | investorshub | 04/24/2023 11:45:07 PM |
$TEVA Time for a bounce? | JLS | investorshub | 04/24/2023 5:12:58 AM |
$TEVA MomentumIts gaining up | WovenO2 | investorshub | 04/24/2023 2:24:48 AM |
$TEVA short squeeze article | Zilla | investorshub | 04/22/2023 8:03:09 PM |
Have a look at this | Melia10 | investorshub | 04/19/2023 9:05:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) attempt to revive patents...
2024-04-19 05:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva SELARSDI is expected to be marketed in the U.S. on or after February 21, 2025, following a settlement agreement with Johnso...